These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20409316)
1. Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. Bae JS; Choi JS; Baik SH; Park WC; Song BJ; Kim JS; Lim Y; Jung SS World J Surg Oncol; 2010 Apr; 8():32. PubMed ID: 20409316 [TBL] [Abstract][Full Text] [Related]
2. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. Hawthorn L; Luce J; Stein L; Rothschild J BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942 [TBL] [Abstract][Full Text] [Related]
3. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization. Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796 [TBL] [Abstract][Full Text] [Related]
4. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. Ghazani AA; Arneson N; Warren K; Pintilie M; Bayani J; Squire JA; Done SJ Neoplasia; 2007 Jun; 9(6):511-20. PubMed ID: 17603634 [TBL] [Abstract][Full Text] [Related]
5. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588 [TBL] [Abstract][Full Text] [Related]
6. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. Han W; Han MR; Kang JJ; Bae JY; Lee JH; Bae YJ; Lee JE; Shin HJ; Hwang KT; Hwang SE; Kim SW; Noh DY BMC Cancer; 2006 Apr; 6():92. PubMed ID: 16608533 [TBL] [Abstract][Full Text] [Related]
7. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471 [TBL] [Abstract][Full Text] [Related]
8. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Loo LW; Grove DI; Williams EM; Neal CL; Cousens LA; Schubert EL; Holcomb IN; Massa HF; Glogovac J; Li CI; Malone KE; Daling JR; Delrow JJ; Trask BJ; Hsu L; Porter PL Cancer Res; 2004 Dec; 64(23):8541-9. PubMed ID: 15574760 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of metaplastic squamous cell carcinoma of the breast inter- and intratumoral heterogeneity. Oikawa M; Igawa A; Taguchi K; Baba K; Ishida M; Akiyoshi S; Yano H; Nagayasu T; Ohno S; Tokunaga E Breast Cancer; 2017 Nov; 24(6):733-741. PubMed ID: 28316008 [TBL] [Abstract][Full Text] [Related]
10. Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer. Han S; Park K; Shin E; Kim HJ; Kim JY; Kim JY; Gwak G Oncol Rep; 2010 Jul; 24(1):121-8. PubMed ID: 20514452 [TBL] [Abstract][Full Text] [Related]
11. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610 [TBL] [Abstract][Full Text] [Related]
12. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer. Chao HH; He X; Parker JS; Zhao W; Perou CM PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754 [TBL] [Abstract][Full Text] [Related]
13. The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome. Przybytkowski E; Ferrario C; Basik M BMC Med Genomics; 2011 Jan; 4():16. PubMed ID: 21272361 [TBL] [Abstract][Full Text] [Related]
15. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization. Günther K; Merkelbach-Bruse S; Amo-Takyi BK; Handt S; Schröder W; Tietze L J Pathol; 2001 Jan; 193(1):40-7. PubMed ID: 11169514 [TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization (CGH) analysis of chromosomal aberrations in Iranian patients with invasive ductal carcinoma breast cancer. Ghaffari SR; Sabokbar T; Pour PN; Dastan J; Mehrkhani F; Shoraka S; Mohagheghi MA; Tirgari F; Mosavi-Jarrahi A Asian Pac J Cancer Prev; 2008; 9(1):66-70. PubMed ID: 18439077 [TBL] [Abstract][Full Text] [Related]
17. Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours. Kuijper A; Snijders AM; Berns EM; Kuenen-Boumeester V; van der Wall E; Albertson DG; van Diest PJ Cell Oncol; 2009; 31(1):31-9. PubMed ID: 19096148 [TBL] [Abstract][Full Text] [Related]
18. Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers. Geiersbach KB; Willmore-Payne C; Pasi AV; Paxton CN; Werner TL; Xu X; Wittwer CT; Gulbahce HE; Downs-Kelly E Am J Clin Pathol; 2016 Oct; 146(4):439-47. PubMed ID: 27614666 [TBL] [Abstract][Full Text] [Related]
19. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Johnson CE; Gorringe KL; Thompson ER; Opeskin K; Boyle SE; Wang Y; Hill P; Mann GB; Campbell IG Breast Cancer Res Treat; 2012 Jun; 133(3):889-98. PubMed ID: 22052326 [TBL] [Abstract][Full Text] [Related]
20. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization. Gao Y; Niu Y; Wang X; Wei L; Lu S J Mol Med (Berl); 2009 Feb; 87(2):145-52. PubMed ID: 18936904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]